ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,101 Cr | ₹979 Cr | ₹730 Cr | ₹-79 Cr | ₹-109 Cr |
What is the latest Total Non-Current Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,101 Cr |
| Mar2024 | ₹979 Cr |
| Mar2023 | ₹730 Cr |
| Mar2022 | ₹-79 Cr |
| Mar2021 | ₹-109 Cr |
How is Total Non-Current Liabilities of ERIS LIFESCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,101 Cr | 114.53 | |
| Mar2024 | ₹979 Cr | 34.15 | |
| Mar2023 | ₹730 Cr | Positive | |
| Mar2022 | ₹-79 Cr | Negative | |
| Mar2021 | ₹-109 Cr | - | |
Compare Total Non-Current Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹21,002.0 Cr | 2.8% | -1.1% | 15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,121.0 Cr | 0.6% | -4.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,918.0 Cr | -1% | -1.7% | 5.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,960.0 Cr | 1.3% | 1.8% | 13.7% | Stock Analytics | |
| CIPLA | ₹122,725.0 Cr | 1.9% | -0.1% | -1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,224.0 Cr | -1.4% | -2.2% | -8.3% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 2.8% |
-1.1% |
15% |
| SENSEX | 0.9% |
0.4% |
9.3% |
You may also like the below Video Courses